Journal article icon

Journal article

Bronchodilator reversibility in asthma and COPD: Findings from three large population studies

Abstract:

Bronchodilator response (BDR) testing is used as a diagnostic method in obstructive airway diseases. The aim of this investigation was to compare different methods for measuring BDR in participants with asthma and COPD and to study to the extent to which BDR was related to symptom burden and phenotypic characteristics.
Forced expiratory volume in one second (FEV1) and forced vital capacity (FVC) was measured before and 15 min after 200 μg of salbutamol in 35 628 subjects aged 16 years and older from three large international population studies. The subjects were categorised in three groups: current asthma (n=2833), COPD (n=1146), and no airway disease (n=31 649). Three definitions for flow related (increase in FEV1) and three for volume related (increase in FVC) were used.
The prevalence of bronchodilator reversibility expressed as increase FEV1≥12% and 200 mL was 17.3% and 18.4% in participants with asthma and COPD, respectively, while the corresponding prevalence was 5.1% in those with no airway disease. In asthma, bronchodilator reversibility was associated with wheeze (OR (95% CI): 1.36 (1.04-1.79)), atopy (OR 1.36 (1.04-1.79)) and higher FeNO while in COPD neither flow nor volume related bronchodilator reversibility was associated with symptom burden, exacerbations or health status after adjusting for prebronchodilator FEV1.
Bronchodilator reversibility was at least as common in participants with COPD as those with asthma. This indicates that measures of reversibility are of limited value for distinguishing asthma from COPD in population studies. In asthma, however, bronchodilator reversibility may be a phenotypic marker.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Publisher copy:
10.1183/13993003.00561-2019

Authors


More by this author
Role:
Author
ORCID:
0000-0001-5093-6980


Publisher:
European Respiratory Society
Journal:
European Respiratory Journal More from this journal
Volume:
54
Issue:
2
Article number:
1900561
Publication date:
2019-06-20
Acceptance date:
2019-05-29
DOI:
EISSN:
1399-3003
ISSN:
0903-1936
Pmid:
31221806


Language:
English
Keywords:
Pubs id:
pubs:1027052
UUID:
uuid:b6b08dc8-104f-4dab-a5aa-9bccfa6c1da2
Local pid:
pubs:1027052
Source identifiers:
1027052
Deposit date:
2019-08-19

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP